fbpx
2 C
London
Saturday, January 16, 2021

ALXN

- Advertisement -

Alexion Pharmaceuticals, Inc (NASDAQ: ALXN) Price Target Upgraded To $121.00

Analysts at Morgan Stanley raised the price target of Alexion Pharmaceuticals (NASDAQ: ALXN) to $121.00 on Tuesday. This is up from the earlier $120.00....
- Advertisement -

Must Read

- Advertisement -